drugset / Trial / NCT00480649

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

NCT00480649 ↗

Phase 4 Completed 424 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary study objective is to demonstrate the clinical effectiveness of SERETIDE therapy compared to the current care in management of moderate to severe persistent asthma patients in Korea.

Timeline

Start
2004-01
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salmeterol/ fluticasone propionate Unknown — —

Indications